Influence of the anion on the coordination mode of an unsymmetrical N-heterocyclic ligand in Cd(II) complexes: From discrete molecule to one- and two-dimensional structures

Five new 0D–2D Cd(II) complexes, [Cd₂(Hbimt)₂I₄] (1), [Cd(bimt)(Hbimt)Br]_n (2), [Cd(Hbimt)Cl₂(H₂O)]_n (3), {[Cd(Hbimt)(SO₄)(H₂O)₂]·1.5H₂O}_n (4) and [Cd(Hbimt)(SCN)₂]_n (5) (Hbimt = 2-((benzoimidazol-yl)methyl)-1H-tetrazole) have been synthesized by the reactions of Hbimt with suitable cadmium salts. Employment of different anions can influence the coordination modes of the Hbimt ligand, and accordingly result in different structures ranging from 0D to infinite 1D and 2D networks. Complex 1 displays a dimeric structure in which two Cd(II) ions are bridged through two iodine atoms. Complex 2 was caused by deprotonation of the Hbimt ligand, resulting in a 1D helical chain. While in complexes 3 and 4, Hbimt acts as a bidentate bridging ligand which joins two Cd(II) ions, leading to 1D stair-like chains. Complex 5 exhibits a 2D network structure with infinite 1D [Cd₂(SCN)₂]_n chains. The distinct structures of 1, 2, 3, 4 and 5 reveal that the anions and the versatile coordination modes of the ligand play an important role in the structures of the complexes. In addition, the luminescent properties of complexes 1–5 have been investigated in the solid state at room temperature.     

Anion detection by aggregation-induced enhanced emission (AIEE) of urea-functionalized tetraphenylethylenes

Substituted tetraphenylethylenes (TPEs) have been prepared that feature four alkyl or aryl urea groups arrayed along the periphery. Exposure of these TPEs to monovalent anions (halide, carboxylate, nitrate, and azide) resulted in enhanced fluorescence emission attributed to aggregation of the TPE molecules via urea-anion hydrogen bonding. Emission enhancement correlated with anion basicity, with fluoride ion eliciting the largest fluorescence response. Increased fluorescence emission could also be detected visually in solutions viewed under UV light. This study demonstrates the feasibility of TPE-based fluorescent anion sensors/detectors, and it is envisioned that additional design modifications may afford anion-selective fluorescent sensors.     

基于偶氮水杨醛酰腙的氰根比色检测探针的合成及性能

设计合成了一种基于酚羟基和氨基的酰腙类探针分子, 利用紫外-可见吸收光谱和核磁滴定考察了其对F^-, Cl^-, Br^-, I^-, CH₃COO^-, H₂PO₄^-, HSO₄^-, ClO₄^-, CN^-, SCN^-, SO^2-₄和NO^-₃等阴离子的识别作用. 结果表明, 当加入CN^-离子时主体溶液颜色由无色变为黄色, 而加入其它离子时主体溶液颜色不变, 说明该探针在DMSO/H₂O(体积比5: 5)体系中能选择性裸眼比色检测CN^-. 核磁滴定及质谱数据表明, 该探针与CN^-以1:1化学计量比结合, 该过程通过亲核加成方式完成.     

新型中性载体硫氰酸根离子选择电极研究

系统研究了新型Schiff碱[N,N'-双-(4-苯偶氮水杨醛)缩邻苯二胺]过渡金属配合物的阴离子响应行为.实验结果表明,配合物中心金属原子的结构与电极的响应行为之间有非常密切的构效关系,其中Mn(Ⅱ)的配合物对硫氰酸根有优良的电位响应性能和选择性,该电极的线性范围为0.14.3×10^-6mol/L,斜率为-58.0mV/dec.,其反Hofmeister选择性次序为SCN^->I^->Sal^->PhCO₂^->ClO₄^->NO₂^->Br^->Ac^->NO₃^->Cl^-.通过交流阻抗和膜相中荷电离子的添加实验证实,该电极对阴离子的响应系中性载体作用机制.该电极具有读数稳定,选择性和重现性好等优点,可直接应用于废水中硫氰酸盐的测定.     

Synthesis and Structure–Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents

P2X3 receptors (P2X3R) are ATP-gated ion channels predominantly expressed in C- and Aδ-fiber primary afferent neurons and have been introduced as a novel therapeutic target for neurological disorders, including neuropathic pain and chronic cough. Because of its localized distribution, antagonism of P2X3R has been thoroughly considered, and the avoidance of issues related to CNS side effects has been proven in clinical trials. In this article, benzimidazole-4,7-dione-based derivatives were introduced as a new chemical entity for the development of P2X3R antagonists. Starting from the discovery of a hit compound from the screening of 8364 random library compounds in the Korea Chemical Bank, which had an IC₅₀ value of 1030 nM, studies of structure–activity and structure–property relationships enabled further optimization toward improving the antagonistic activities as well as the drug’s physicochemical properties, including metabolic stability. As for the results, the final optimized compound 14h was developed with an IC₅₀ value of 375 nM at P2X3R with more than 23-fold selectivity versus P2X2/3R, along with properties of metabolic stability and improved solubility. In neuropathic pain animal models evoked by either nerve ligation or chemotherapeutics in male Sprague-Dawley rats, compound 14h showed anti-nociceptive effects through an increase in the mechanical withdrawal threshold as measured by von Frey filament following intravenous administration.     

柱切换离子色谱法测定丙酮中痕量阴离子

建立了测定丙酮中痕量阴离子的离子色谱分析方法.采用的是高效液相柱切换进样,其中泵的流速为0.5 mL/min,使低浓度的丙酮水溶液在保护柱上富集,通过离子色谱抑制电导法分离和检测丙酮样品中痕量的阴离子.色谱条件为:以IonPacAG9-HC(50 mm×2 mm)型柱串联在定量环中进行富集,IonPacAG9-HC(50 mm×2 mm)保护柱,IonPac AS9-HC(250 mm×2 mm)阴离子分离柱进行分离,流动相为9 mmol/L Na2CO3-1.667 mol/L NaHCO3,所得回收率在96.21%～101.56%之间,线性良好,且具有较好的重现性和较低的检出限.     

Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System

Ligands of the G_i protein-coupled adenosine A₃ receptor (A₃R) are receiving increasing interest as attractive therapeutic tools for the treatment of a number of pathological conditions of the central and peripheral nervous systems (CNS and PNS, respectively). Their safe pharmacological profiles emerging from clinical trials on different pathologies (e.g., rheumatoid arthritis, psoriasis and fatty liver diseases) confer a realistic translational potential to these compounds, thus encouraging the investigation of highly selective agonists and antagonists of A₃R. The present review summarizes information on the effect of latest-generation A₃R ligands, not yet available in commerce, obtained by using different in vitro and in vivo models of various PNS- or CNS-related disorders. This review places particular focus on brain ischemia insults and colitis, where the prototypical A₃R agonist, Cl-IB-MECA, and antagonist, MRS1523, have been used in research studies as reference compounds to explore the effects of latest-generation ligands on this receptor. The advantages and weaknesses of these compounds in terms of therapeutic potential are discussed.     

Automated Synthesis of 68Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting

The new minigastrin analog DOTA-MGS8 targeting the cholecystokinin-2 receptor (CCK2R) used in this study displays the combination of two site-specific modifications within the C-terminal receptor binding sequence together with an additional N-terminal amino acid substitution preventing fast metabolic degradation. Within this study, the preparation of ⁶⁸Ga-labeled DOTA-MGS8 was validated using an automated synthesis module, describing the specifications and analytical methods for quality control for possible clinical use. In addition, preclinical studies were carried out to characterize the targeting potential. [⁶⁸Ga]Ga-DOTA-MGS8 showed a high receptor-specific cell internalization into AR42J rat pancreatic cells (~40%) with physiological expression of rat CCK2R as well as A431-CCK2R cells transfected to stably express human CCK2R (~47%). A favorable biodistribution profile was observed in BALB/c nude mice xenografted with A431-CCK2R cells and mock-transfected A431 cells as control. The high tumor uptake of ~27% IA/g together with low background activity and limited uptake in non-target tissue confirms the potential for high-sensitivity positron emission tomography of stabilized MG analogs in patients with MTC and other CCK2R-related malignancies.